uniQure's Convertible Note Round

uniQure raised a round of funding on May 14, 2013.

uniQure is delivering on the promise of gene therapy, single treatments with potentially curative results. The company has developed a modular platform to rapidly bring new disease modifying therapies…

Articles about uniQure's Convertible Note Round: